| 发明名称 |
DIAGNOSTIC METHOD |
| 摘要 |
The invention relates to a method of diagnosing or assessing an inflammatory bowel disease in a subject, comprising comparing the level of one or more markers in a tissue or body fluid of the subject relative to a reference value for the one or more markers, wherein the marker is selected from the group consisting of Secretogranin-1 or a fragment thereof, guanylin or a fragment thereof, SPP 24 or a fragment thereof, AMBP or a fragment thereof; and serglycin or a fragment thereof. |
| 申请公布号 |
US2016161503(A1) |
申请公布日期 |
2016.06.09 |
| 申请号 |
US201414900867 |
申请日期 |
2014.06.27 |
| 申请人 |
NEWSOUTH INNOVATIONS PTY LIMITED ;SYDNEY LOCAL HEALTH DISTRICT |
发明人 |
WASINGER Valerie Christine;LEONG Rupert Wing-Loong |
| 分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of diagnosing or assessing an inflammatory bowel disease in a subject, comprising comparing the level of one or more markers in a tissue or body fluid of the subject relative to a reference value for the one or more markers, wherein the marker is selected from the group consisting of:
(i) Secretogranin-1 or a fragment thereof; (ii) guanylin or a fragment thereof; (iii) SPP 24 or a fragment thereof; (iv) AMBP or a fragment thereof; and (v) serglycin or a fragment thereof. |
| 地址 |
New South Wales AU |
